Nine Months Ended

(In Millions; Unaudited)

Sep 30, 2023

Oct 1, 2022

Cash and cash equivalents, beginning of period

$         11,144

$          4,827

Cash flows provided by (used for) operating activities:

Net income (loss)

             (985)

            8,678

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation

            5,753

            8,309

Share-based compensation

            2,433

            2,392

Restructuring and other charges

               718

               665

Amortization of intangibles

            1,336

            1,439

(Gains) losses on equity investments, net

                47

           (4,075)

(Gains) losses on divestitures

                 -

           (1,072)

Changes in assets and liabilities:

Accounts receivable

            1,290

            1,991

Inventories

            1,758

           (2,043)

Accounts payable

           (1,082)

             (485)

Accrued compensation and benefits

           (1,171)

           (1,912)

Income taxes

           (2,676)

           (4,062)

Other assets and liabilities

             (574)

           (2,095)

Total adjustments

            7,832

             (948)

Net cash provided by (used for) operating activities

            6,847

            7,730

Cash flows provided by (used for) investing activities:

Additions to property, plant, and equipment

         (19,054)

         (19,145)

Purchases of short-term investments

         (37,287)

         (31,669)

Maturities and sales of short-term investments

          36,725

          35,129

Sales of equity investments

               375

            4,880

Proceeds from divestitures

                 -

            6,579

Other investing

               518

           (2,764)

Net cash used for investing activities

         (18,723)

           (6,990)

Cash flows provided by (used for) financing activities:

Repayment of commercial paper

           (3,944)

                 -

Payments on finance leases

               (96)

             (341)

Partner contributions

            1,106

                 -

Proceeds from sales of subsidiary shares

            2,423

                 -

Issuance of long-term debt, net of issuance costs

          11,391

            6,103

Repayment of debt

             (423)

           (3,088)

Payment of dividends to stockholders

           (2,561)

           (4,488)

Other financing

               457

               776

Net cash provided by (used for) financing activities

            8,353

           (1,038)

Net increase (decrease) in cash and cash equivalents

           (3,523)

             (298)

Cash and cash equivalents, end of period

$          7,621

$          4,529